Our Story
We modernize labs with controlled build-to-go-live delivery, AI decision support, and audit-ready evidence—plus targeted training when needed.
Our Focus
When Labs underperform, Patients pay the Price—and Health Systems lose Millions. Usually, technology, workflow, data, and compliance aren’t fully integrated. DealBridge aligns them with controlled execution, AI decision support, operational excellence, risk management, and audit-ready evidence—delivering safer care and measurable cost control.
AI Decision
DealBridge Global was built for one reason: high-stakes diagnostics projects fail when plans don’t turn into execution and accountability breaks across teams and vendors. We align clinical needs, operations, suppliers, and governance into one controlled delivery system—so complex work goes live, performs, and delivers measurable outcomes.
Meet Us
Founder-led leadership, strengthened by senior advisors in lab medicine, pathology, quality, and lab data & AI. We bring governance and delivery discipline that protects patients, budgets, and outcomes.
Founder & Managing Director | DealBridge Global
Dr. Ghulam Dhabaan, PhD, FCCM, D(ABMM), is a board-certified Clinical Microbiologist and Founder of DealBridge Global, a diagnostics advisory, innovation, and execution firm. Trained across University of Toronto–affiliated hospitals, he specializes in transforming complex laboratory systems into high-performance, outcome-driven operations. His work integrates AI-enabled diagnostics, automation, and antimicrobial stewardship to bridge the gap between data, decisions, and clinical impact. Published in Nature Microbiology and The Lancet Microbe, he advises on large-scale diagnostic transformation initiatives across North America and the GCC.
Professor & Head, Clinical Biochemistry | SickKids & University of Toronto | Past President, IFCC
Dr. Khosrow Adeli is Professor and Head of Clinical Biochemistry at the Hospital for Sick Children and the University of Toronto. He served as President of the IFCC (2020–2023) and is Editor-in-Chief of Critical Reviews in Clinical Laboratory Sciences. A fellow of the Canadian Academy of Clinical Biochemistry and diplomate of the American Board of Clinical Biochemistry, he has received numerous distinctions including the University of Toronto Hegele Award and the ADLM Outstanding Research Award. Principal Investigator of the globally adopted CALIPER pediatric reference interval database. Author of 500+ publications.
Professor & Microbiologist-in-Chief, Sinai Health & University Health Network | University of Toronto
Dr. Tony Mazzulli, MD, FRCPC, FACP, is a leading authority in clinical microbiology, infectious diseases, and diagnostic innovation. He serves as Microbiologist-in-Chief at Sinai Health and University Health Network and is a Professor and Clinician Investigator at the University of Toronto. A recognized leader in antimicrobial resistance, virology, and rapid diagnostics, he has authored over 150 peer-reviewed publications and led major laboratory responses to emerging pathogens. Dr. Mazzulli holds key advisory roles with CLSI and national specialty bodies, and has directed premier training programs, shaping the next generation of clinical microbiology leadership.
Founder & MD, Q3CG | Executive Director, QRI | Ann Arbor, Michigan
Dr. Walid Qoronfleh is Executive Director of Q3 Research Institute (QRI) and co-Founder of Q3CG, a boutique healthcare consultancy in Michigan. With 20+ years in precision medicine, AI, and laboratory medicine, he has held senior executive roles at GSK, Sanofi, Thermo Fisher, and the NIH-NCI. He has secured nearly US$20M in funded research and published 145+ peer-reviewed papers and four books, including a best-book award winner. Founder of six biotech companies with three successful exits. Holds graduate degrees from the University of Louisville, Penn State, and University of Wisconsin–Madison.
Group Laboratory Director, Operations & Innovation | American Hospital Dubai
Dr. Hady Elkhodary is a healthcare executive and clinical laboratory leader with 20+ years optimizing diagnostics across Canada and the Middle East. As Group Laboratory Director at American Hospital Dubai, he steers multi-site total laboratory automation, genomics expansion, and data-driven quality programs that have reduced turnaround times and delivered millions in operational savings. A recognized expert in ISO 15189 and CAP accreditation, LIS integration (Oracle Health, TrakCare), and value-based care strategy, he consults with GCC health systems on operational excellence and advances predictive analytics to close diagnostic gaps.
Meet Us
Founder-led leadership, strengthened by senior advisors in lab medicine, pathology, quality, and lab data & AI. We bring governance and delivery discipline that protects patients, budgets, and outcomes.
Founder & Managing Director | DealBridge Global
Dr. Ghulam Dhabaan, PhD, FCCM, D(ABMM), is a board-certified Clinical Microbiologist and Founder of DealBridge Global, a diagnostics advisory, innovation, and execution firm. Trained across University of Toronto–affiliated hospitals, he specializes in transforming complex laboratory systems into high-performance, outcome-driven operations. His work integrates AI-enabled diagnostics, automation, and antimicrobial stewardship to bridge the gap between data, decisions, and clinical impact. Published in Nature Microbiology and The Lancet Microbe, he advises on large-scale diagnostic transformation initiatives across North America and the GCC.
Professor & Head, Clinical Biochemistry | SickKids & University of Toronto | Past President, IFCC
Dr. Khosrow Adeli is Professor and Head of Clinical Biochemistry at the Hospital for Sick Children and the University of Toronto. He served as President of the IFCC (2020–2023) and is Editor-in-Chief of Critical Reviews in Clinical Laboratory Sciences. A fellow of the Canadian Academy of Clinical Biochemistry and diplomate of the American Board of Clinical Biochemistry, he has received numerous distinctions including the University of Toronto Hegele Award and the ADLM Outstanding Research Award. Principal Investigator of the globally adopted CALIPER pediatric reference interval database. Author of 500+ publications.
Founder & MD, Q3CG | Executive Director, QRI | Ann Arbor, Michigan
Dr. Walid Qoronfleh is Executive Director of Q3 Research Institute (QRI) and co-Founder of Q3CG, a boutique healthcare consultancy in Michigan. With 20+ years in precision medicine, AI, and laboratory medicine, he has held senior executive roles at GSK, Sanofi, Thermo Fisher, and the NIH-NCI. He has secured nearly US$20M in funded research and published 145+ peer-reviewed papers and four books, including a best-book award winner. Founder of six biotech companies with three successful exits. Holds graduate degrees from the University of Louisville, Penn State, and University of Wisconsin–Madison.
Group Laboratory Director, Operations & Innovation | American Hospital Dubai
Dr. Hady Elkhodary is a healthcare executive and clinical laboratory leader with 20+ years optimizing diagnostics across Canada and the Middle East. As Group Laboratory Director at American Hospital Dubai, he steers multi-site total laboratory automation, genomics expansion, and data-driven quality programs that have reduced turnaround times and delivered millions in operational savings. A recognized expert in ISO 15189 and CAP accreditation, LIS integration (Oracle Health, TrakCare), and value-based care strategy, he consults with GCC health systems on operational excellence and advances predictive analytics to close diagnostic gaps.
Rationale
DealBridge Global was built after seeing the same failure pattern in diagnostics programs: patients are put at risk, and health systems lose millions through delays, quality failures, rework, and downtime.
Even with great expertise and top vendors, initiatives fail when execution isn’t controlled.
We built a practical model that combines clinical credibility with operational discipline—so leaders reduce risk early, go live with confidence, and sustain performance long after launch.
Delivered Model
We bring structure to complexity through delivery controls that health systems and laboratories can trust
Delivery Team
DealBridge Global is led by a senior, operator-led core team, backed by a curated network of lab medicine and pathology experts as needed.
We cover operations and workflow, quality/accreditation, validation/verification, and data + AI decision support.
Expertise spans all major laboratory disciplines—keeping delivery practical, accountable, and scalable.
Principles
Values that translate into execution. Clear decisions, accountable owners, auditable results.
Decisions, scope, and expectations are explicit
Owners, dates, evidence, and outcomes are tracked
Reliability, traceability, and patient impact first
Aligned stakeholders, practical delivery, no blame culture
Vendor-neutral, risk-aware, and evidence-driven
Founder-led operations and governance.
Delivery support and partnerships across select engagements.
Core growth market—Riyadh and Dubai prioritized (regional presence planned).
Middle East, Africa, and Asia supported based on project fit and strategic alignment.
Where are
We help hospitals, laboratories, and healthcare partners deliver complex diagnostics and technology initiatives. With clinical insight, structured governance, and disciplined execution.
Meet Us
Founder-led leadership, strengthened by senior advisors in lab medicine, pathology, quality, and lab data & AI. We bring governance and delivery discipline that protects patients, budgets, and outcomes.
Founder & Managing Director | DealBridge Global
Dr. Ghulam Dhabaan, PhD, FCCM, D(ABMM), is a board-certified Clinical Microbiologist and Founder of DealBridge Global, a diagnostics advisory, innovation, and execution firm. Trained across University of Toronto–affiliated hospitals, he specializes in transforming complex laboratory systems into high-performance, outcome-driven operations. His work integrates AI-enabled diagnostics, automation, and antimicrobial stewardship to bridge the gap between data, decisions, and clinical impact. Published in Nature Microbiology and The Lancet Microbe, he advises on large-scale diagnostic transformation initiatives across North America and the GCC.
Professor & Head, Clinical Biochemistry | SickKids & University of Toronto | Past President, IFCC
Dr. Khosrow Adeli is Professor and Head of Clinical Biochemistry at the Hospital for Sick Children and the University of Toronto. He served as President of the IFCC (2020–2023) and is Editor-in-Chief of Critical Reviews in Clinical Laboratory Sciences. A fellow of the Canadian Academy of Clinical Biochemistry and diplomate of the American Board of Clinical Biochemistry, he has received numerous distinctions including the University of Toronto Hegele Award and the ADLM Outstanding Research Award. Principal Investigator of the globally adopted CALIPER pediatric reference interval database. Author of 500+ publications.
Founder & MD, Q3CG | Executive Director, QRI | Ann Arbor, Michigan
Dr. Walid Qoronfleh is Executive Director of Q3 Research Institute (QRI) and co-Founder of Q3CG, a boutique healthcare consultancy in Michigan. With 20+ years in precision medicine, AI, and laboratory medicine, he has held senior executive roles at GSK, Sanofi, Thermo Fisher, and the NIH-NCI. He has secured nearly US$20M in funded research and published 145+ peer-reviewed papers and four books, including a best-book award winner. Founder of six biotech companies with three successful exits. Holds graduate degrees from the University of Louisville, Penn State, and University of Wisconsin–Madison.
Group Laboratory Director, Operations & Innovation | American Hospital Dubai
Dr. Hady Elkhodary is a healthcare executive and clinical laboratory leader with 20+ years optimizing diagnostics across Canada and the Middle East. As Group Laboratory Director at American Hospital Dubai, he steers multi-site total laboratory automation, genomics expansion, and data-driven quality programs that have reduced turnaround times and delivered millions in operational savings. A recognized expert in ISO 15189 and CAP accreditation, LIS integration (Oracle Health, TrakCare), and value-based care strategy, he consults with GCC health systems on operational excellence and advances predictive analytics to close diagnostic gaps.
We Are Ready
A short call to understand your constraints, risks, and desired outcomes—then define the fastest controlled path to measurable results.
A short call to understand your constraints, risks, and desired outcomes—then define the fastest controlled path to measurable results.
We bridge clinical expertise and execution teams to deliver diagnostics projects with control, stability, and measurable outcomes.
Toronto, ON, Canada
